The Pharmacists’ Role in Increasing Disease Awareness of Eosinophilic Esophagitis and Facilitating Guideline-directed Therapies
Successful treatment of EoE hinges on an interprofessional approach.
Eosinophilic esophagitis (EoE) is a rare disease that has only been distinguished from gastrointestinal reflux disease since the mid-1990s. This live virtual symposium reviews the complex pathophysiology and clinical presentation of patients with EoE, an often underdiagnosed and undertreated condition. Newly released clinical practice guidelines will be discussed, including evidence-based recommendations and the use of medications, diet modification, and allergy-based testing for pediatric and adult patients. Successful treatment of EoE hinges on an interprofessional approach to care that involves the pharmacists’ expertise in implementing guideline recommendations, optimizing medication therapy, and ensuring proper use of medications in this unique disease state. Emerging treatment strategies currently under development will also be discussed.
Join us for this Virtual Symposium on Monday, Dec. 6, from 9 to 10:30 a.m. ET. Register now at https://www.ashpadvantage.com/eoe/ and explore the full initiative, which includes podcasts, live and enduring webinars, and faculty commentaries.
This activity is provided by ASHP and supported by Takeda Pharmaceuticals U.S.A., Inc.
